Any feedback?
Literature summary for 5.3.99.2 extracted from
- Development of pH-independent drug release formulation using lipocalin-type prostaglandin D synthase (2016), J. Pharm. Sci., 105, 2735-2742 .
Protein Variants
| Protein Variants | Comment | Organism |
|---|---|---|
| C65A/C167A | the mutations abolish enzymatic activity | Homo sapiens |
Natural Substrates/ Products (Substrates)
| Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| Prostaglandin H2 | Homo sapiens | - |
Prostaglandin D2 | - |
? |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | P41222 | - |
- |
Substrates and Products (Substrate)
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| Prostaglandin H2 | - |
Homo sapiens | Prostaglandin D2 | - |
? | |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| L-PGDS | - |
Homo sapiens |
| lipocalin-type prostaglandin d synthase | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
